Adherence to Antiretroviral Therapy, and Quality of Life in People Living with HIV: A Prospective Study-Reference-Cited by-同舟云学术

Adherence to Antiretroviral Therapy, and Quality of Life in People Living with HIV: A Prospective Study

Published:2024-03-20 Issue:1 Volume:17 Page:417-423
ISSN:2456-2610
Container-title:Biomedical and Pharmacology Journal
language:en
Short-container-title:Biomed. Pharmacol. J.

Author:

Balaji R Abhishek¹^ORCID,Kamath Priyanka²,Rathi Priya³^ORCID,Madi Deepak⁴^ORCID

Affiliation:

1. 1Department of Surgery, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, India.

2. 2Department of Pharmacology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, India.

3. 3Department of Community Medicine, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, India.

4. 4Department of Medicine, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, India.

Abstract

Background Combination antiretroviral therapy (ART) is the cornerstone of management of patients with HIV, and a strict adherence to the same is of utmost importance in success of therapy. Treatment in most cases, once started has to be taken life-long, and hence compliance can be an issue. With newer once-a-day regimens, there could be a positive impact on both the adherence to the treatment and the quality of life (QOL); assessing these various factors was the purpose of this study. Methods This observational longitudinal study was conducted at a teaching hospital offering tertiary care in Coastal Karnataka, and the study population consisted of 198 patients with HIV of both genders, on ART. All patients aged over 18 years, who were HIV positive and on ART from at least one month were included. Data was collected by directly interviewing the patient through the questionnaire at the ART clinic. Results A total of 198 patients were interviewed, and assessed for adherence to ART using the Medication Adherence Questionnaire (MAQ), a validated questionnaire. The quality of life was assessed using the WHOQOL questionnaire, again a validated and elaborate questionnaire. Of the total patients, 103 were males. According to MAQ scale, a medium to high level of adherence was observed in 97.5% of the patients (score 0 is high adherence, score of 1 or 2 is medium adherence). Regarding the QOL, 43% of them responded to having good energy levels and being able to perform their daily activities without difficulty, over 80% of them said they were able to work normally, and able to carry out their duties, along with being satisfied with their capacity to work. Conclusion The adherence to antiretroviral therapy was observed to be >95% in majority of the patients when assessed using the Medication Adherence Questionnaire, which is very good. The quality of life was deemed to be satisfactory when assessed using the WHOQOL questionnaire.

Publisher

Oriental Scientific Publishing Company

Reference29 articles.

1. 1. Fauci AS, Lane HC. Human Immunodeficiency Virus Disease: AIDS & Related Disorders. In, Longo DL, Kasper DL, Jameson JL, Fauci AS, Loscalzo J, editors. Harrisons Principles of Internal Medicine, 18th ed. New York: The McGraw Hill Companies; 2012. p. 1506-07.

2. 2. Flexner C. Antiretroviral Agents and Treatment of HIV Infection. In, Brunton LB, Chabner BA, Knollman BC,editors. Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 12th ed. New York: The McGraw Hill Companies; 2011. p. 1628-59.

3. 3. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21-30.

4. 4. Sethi AK, Celentano DD, Gange SJ, Moore RD, Gallant JE. Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clin Infect Dis. 2003;37(8):1112-18.

5. 5. Wood E, Hogg RS, Yip B, Harrigan PR, O’Shaughnessy MV, Montaner JS. Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy? AIDS. 2003;17(5):711-20.